It is currently Thu Oct 27, 2016 11:31 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

RRMS dx received

I finally (after more messing around than I can be bothered to type) got an MS dx today. Am feeling remarkably cheerful despite this because I finally have some answers.

Because the doctor I was supposed to see was out I need to back another time to discuss any meds so at today I just got the dx and had a few q's answered.
Read more : RRMS dx received | Views : 2257 | Replies : 12 | Forum : General Discussion

Bone marrow trial in Kentucky

If someone on here tries this and it is a success you owe me a $100 (that's fair isn't it?)

Read more : Bone marrow trial in Kentucky | Views : 2008 | Replies : 2 | Forum : Stem Cells


An update from AAN on the BHT-3009 phase 2a trial...not bad, not great...

Bayhill Therapeutics Presents Data From a Phase II Trial of BHT-3009 in Multiple Sclerosis at American Academy of Neurology 60th Annual Meeting - Bayhill Therapeutics, Inc. today announced that the Company's co-founder and Vice President of Research, Hideki Garren, M.D., Ph.D., gave a podium presentation at the American Academy of Neurology 60th Annual Meeting (AAN) ...
Read more : BHT-3009 | Views : 1679 | Replies : 1 | Forum : Drug Pipeline

Pork Plant update

Call me crazy...but I'm hoping that this situation will lead to further understanding of MS. Still more pork plant workers are contracting this brand new type of inflammatory neuropathy. A unique pattern of antibodies has been found in all the workers. ... essupdate/

New details on the neurological illness that has affected workers at several pork processing plants will be presented at the American Academy of Neurology’s 60th ...
Read more : Pork Plant update | Views : 1641 | Replies : 2 | Forum : General Discussion

CRABS- the drugs not the bugs

What do you think is the rough number of the people using any of the CRAB drugs world wide for their MS?
Read more : CRABS- the drugs not the bugs | Views : 3849 | Replies : 19 | Forum : General Discussion

pressure sores, WC bound

Well, what can be done to reduce the pressure from sitting on your bum all day... when "moving around" is not an option?? :roll:
Read more : pressure sores, WC bound | Views : 2200 | Replies : 8 | Forum : General Discussion

"60 Minutes" article on potential cancer cure

As a fan of the CBS program, "60 Minutes," I was watching Sunday evening and caught this item: ... tpop_story

It offers hope for a cancer cure. Perhaps this will be our year for one in MS?
Read more : "60 Minutes" article on potential cancer cure | Views : 1609 | Replies : 0 | Forum : General Discussion

FTY720 Phase 2 extension results

Novartis's FTY720 cuts multiple sclerosis attacks

ZURICH, April 15 (Reuters) - Novartis AG's (NOVN.VX: Quote, Profile, Research) once-daily FTY720 pill reduced the number of attacks suffered by patients with multiple sclerosis (MS) after three years, according to data presented on Tuesday.

Nearly three-quarter of patients taking a 5 milligram dose of FTY720, and 68 percent on a 1.25 mg dose, remained free of attacks after three years, Novartis said in a statement.

"All of the ...
Read more : FTY720 Phase 2 extension results | Views : 2059 | Replies : 3 | Forum : Drug Pipeline

Rituxan Joins List That Fail for Severe Form of MS

Wall Street Journal April 15th 2008 ... TU4Wj.html

Rituxan Joins List of Treatments That Fail for Severe Form of MS


April 15, 2008; Page B9

Rituxan, a top-selling drug from Genentech Inc. and Biogen Idec Inc., failed to slow the course of the most severe form of multiple sclerosis in a large study, the companies said.

The findings make Rituxan at least the sixth ...
Read more : Rituxan Joins List That Fail for Severe Form of MS | Views : 1548 | Replies : 0 | Forum : Drug Pipeline

Phase I/II Data presented at the AAN ... 26680.html

Opexa Therapeutics Presents Tovaxin Phase I/II Data at the American Academy of Neurology 60th Annual Meeting

THE WOODLANDS, Texas — Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced that Brian Loftus, M.D., of Bellaire Neurology and the Principal Investigator of the Tovaxin Phase I/II studies, presented data titled "Autologous Attenuated T-Cell Vaccine (Tovaxin(R)) Dose Escalation in ...
Read more : Phase I/II Data presented at the AAN | Views : 2193 | Replies : 5 | Forum : Tcelna (Tovaxin)


Login  •  Register


Total posts 234639 • Total topics 25265 • Total members 16465

Contact us | Terms of Service